Technetium (99mTc) mebrofenin

A radiopharmaceutical used in hepatobiliary imaging

Structure of Technetium (99mTc) mebrofenin

Technetium (99mTc) mebrofenin is a radiopharmaceutical used primarily in nuclear medicine for hepatobiliary imaging. It is a diagnostic agent that helps in the evaluation of the liver, gallbladder, and bile ducts. This compound is particularly useful in assessing the function of the liver and the patency of the bile ducts.

Chemical Composition

Technetium (99mTc) mebrofenin is a complex of the radioisotope technetium-99m with the ligand mebrofenin. The chemical structure of mebrofenin allows it to bind with technetium-99m, forming a stable complex that can be used for imaging purposes. The molecular structure of mebrofenin is designed to facilitate rapid uptake by the liver and excretion into the bile.

Mechanism of Action

Once administered intravenously, technetium (99mTc) mebrofenin is rapidly taken up by the hepatocytes in the liver. The compound is then excreted into the bile, allowing for visualization of the biliary system. The uptake and excretion of the radiopharmaceutical are dependent on the functional capacity of the liver and the patency of the bile ducts. This makes it an effective tool for evaluating hepatic function and detecting biliary obstruction.

Clinical Applications

Technetium (99mTc) mebrofenin is used in a variety of clinical scenarios, including:

• Evaluation of Liver Function: It helps in assessing the functional status of the liver, particularly in patients with liver disease or jaundice.
• Detection of Biliary Obstruction: The radiopharmaceutical can identify blockages in the bile ducts, which may be due to gallstones, tumors, or other causes.
• Assessment of Biliary Atresia: In infants, it is used to differentiate between biliary atresia and other causes of neonatal jaundice.
• Preoperative Evaluation: It can be used to assess liver function before hepatic surgery or liver transplantation.

Procedure

The procedure for a hepatobiliary scan using technetium (99mTc) mebrofenin involves the intravenous injection of the radiopharmaceutical. Imaging is typically performed using a gamma camera to capture the distribution of the radiotracer in the liver and biliary system. The entire process usually takes about 1-2 hours, during which images are taken at various intervals to assess the uptake and excretion of the compound.

Safety and Side Effects

Technetium (99mTc) mebrofenin is generally well-tolerated, with few side effects. The most common adverse reactions are mild and may include nausea, vomiting, or a rash. As with any radiopharmaceutical, there is a small risk of radiation exposure, but the benefits of accurate diagnosis typically outweigh these risks.

Related Pages

• Technetium-99m
• Hepatobiliary imaging
• Nuclear medicine
• Radiopharmaceutical